Literature DB >> 25159929

Recent advances in bulbar syndromes: genetic causes and disease mechanisms.

Andreea Manole1, Pietro Fratta, Henry Houlden.   

Abstract

PURPOSE OF REVIEW: With advances in next-generation gene sequencing, progress in deep phenotyping and a greater understanding of the pathogenesis of motor neuron disease, our knowledge of the progressive bulbar syndromes has significantly increased in recent years. This group of heterogeneous conditions, in which the primary disorder is focused around degeneration of the lower cranial nerves, can occur in children or adults and form a spectrum of severity, based around the common feature of bulbar dysfunction. Early genetic diagnosis may allow treatment in some bulbar syndromes. RECENT
FINDINGS: Brown-Vialetto-Van Laere and Fazio-Londe syndromes are the most recent childhood forms of progressive bulbar palsy to be genetically defined. The clinical phenotype of this group of childhood disorders was first reported over 120 years ago. Recently, it was demonstrated that in a third of these patients Brown-Vialetto-Van Laere is caused by mutations in the SLC52A2 and SLC52A3 genes, both of which encode riboflavin transporters. Importantly, supplementation of riboflavin can lead to significant clinical improvement if started early in the disease process.
SUMMARY: Here, we outline the clinical features, management and an update on the disease mechanisms and genetic causes of the progressive bulbar syndromes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25159929     DOI: 10.1097/WCO.0000000000000133

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  5 in total

1.  EGR2 mutation enhances phenotype spectrum of Dejerine-Sottas syndrome.

Authors:  Elena Gargaun; Andreea Mihaela Seferian; Ruxandra Cardas; Anne-Gaelle Le Moing; Catherine Delanoe; Juliette Nectoux; Isabelle Nelson; Gisèle Bonne; Marie-Thérèse Bihoreau; Jean-François Deleuze; Anne Boland; Cécile Masson; Laurent Servais; Teresa Gidaro
Journal:  J Neurol       Date:  2016-05-09       Impact factor: 4.849

2.  In Vivo Imaging of Human Sarcomere Twitch Dynamics in Individual Motor Units.

Authors:  Gabriel N Sanchez; Supriyo Sinha; Holly Liske; Xuefeng Chen; Viet Nguyen; Scott L Delp; Mark J Schnitzer
Journal:  Neuron       Date:  2015-12-16       Impact factor: 17.173

3.  Disruption of Slc52a3 gene causes neonatal lethality with riboflavin deficiency in mice.

Authors:  Hiroki Yoshimatsu; Atsushi Yonezawa; Kaori Yamanishi; Yoshiaki Yao; Kumiko Sugano; Shunsaku Nakagawa; Satoshi Imai; Tomohiro Omura; Takayuki Nakagawa; Ikuko Yano; Satohiro Masuda; Ken-Ichi Inui; Kazuo Matsubara
Journal:  Sci Rep       Date:  2016-06-08       Impact factor: 4.379

4.  Cochlear Implant in Brown-Vialetto-Van Laere Syndrome Patient.

Authors:  Maria Stella Arantes do Amaral; Eduardo T Massuda; Guilherme Henrique Mitikami Fenólio; Ana Cláudia Mirândola Barbosa Reis; Miguel Angelo Hyppolito
Journal:  J Int Adv Otol       Date:  2022-03       Impact factor: 1.316

5.  Clinical, pathological and functional characterization of riboflavin-responsive neuropathy.

Authors:  Andreea Manole; Zane Jaunmuktane; Iain Hargreaves; Marthe H R Ludtmann; Vincenzo Salpietro; Oscar D Bello; Simon Pope; Amelie Pandraud; Alejandro Horga; Renata S Scalco; Abi Li; Balasubramaniem Ashokkumar; Charles M Lourenço; Simon Heales; Rita Horvath; Patrick F Chinnery; Camilo Toro; Andrew B Singleton; Thomas S Jacques; Andrey Y Abramov; Francesco Muntoni; Michael G Hanna; Mary M Reilly; Tamas Revesz; Dimitri M Kullmann; James E C Jepson; Henry Houlden
Journal:  Brain       Date:  2017-11-01       Impact factor: 13.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.